<?xml version="1.0" encoding="UTF-8" standalone="yes"?><?xml-stylesheet type="text/xsl" href="/oai-pmh-repository/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2026-10-14T17:10:47Z</responseDate>
    <request verb="GetRecord" identifier="oai:data.mendeley.com/5rc36wsph8.1" metadataPrefix="oai_dc">https://data.mendeley.com/oai</request>
    <GetRecord>
        <record>
            <header>
                <identifier>oai:data.mendeley.com/5rc36wsph8.1</identifier>
                <datestamp>2020-02-21T12:49:47Z</datestamp>
            </header>
            <metadata><oai_dc:dc xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <dc:creator>Brioschi, Maura</dc:creator>
    <dc:title>Impact of Surfactant protein B (SP-B) on high density lipoprotein (HDL) oxidation index</dc:title>
    <dc:publisher>Mendeley Data</dc:publisher>
    <dc:description>Circulating immature surfactant protein B (proSP-B) forms emerged as the most reliable lung-specific circulating marker for alveolar-capillary membrane (ACM) dysfunction and for the overall clinical status of heart failure. Of note, ProSP-B forms were detectable in high-density lipoprotein (HDL) only. Thus we assessed the impact of proSP-B on HDL functions using HDL from healthy subjects enriched with proSP-B produced by a stably transfected CHO cell line that specifically expresses and releases the human proSP-B. In particular, HDL antioxidant capacity (HOI) has been assessed in terms of ability to inhibit air-induced LDL oxidation. Data from this dataset demonstrated that HOI was impaired after proSP-B enrichment (Table1). HOI was also higher in HF patients with respect to age-matched control healthy subjects (Table2).</dc:description>
    <dc:subject>Heart Failure</dc:subject>
    <dc:contributor>Banfi, Cristina</dc:contributor>
    <dc:contributor>Gianazza, Erica</dc:contributor>
    <dc:contributor>Agostoni, Piergiuseppe </dc:contributor>
    <dc:type>Dataset</dc:type>
    <dc:identifier>doi:10.17632/5rc36wsph8.1</dc:identifier>
    <dc:identifier>oai:data.mendeley.com/5rc36wsph8.1</dc:identifier>
    <dc:rights>Creative Commons Attribution 4.0 International</dc:rights>
    <dc:rights>http://creativecommons.org/licenses/by/4.0</dc:rights>
    <dc:relation>https://data.mendeley.com/datasets/5rc36wsph8</dc:relation>
    <dc:date>2020-02-21T12:49:47Z</dc:date>
</oai_dc:dc></metadata>
        </record>
    </GetRecord>
</OAI-PMH>
